Racemoramide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-yl-butan-1-one | |
| Clinical data | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
545-59-5 |
| ATC code | none |
| PubChem | CID 9648 |
| ChemSpider |
9269 |
| UNII |
L3J8QT828G |
| Chemical data | |
| Formula | C25H32N2O2 |
| Molar mass | 392.534 g/mol |
| |
| |
| | |
Racemoramide (INN, BAN), or simply moramide, is an opioid analgesic and a racemic mixture of the substances dextromoramide (the active component) and levomoramide (which is inactive), two enantiomers of a chiral molecule.[1]
Racemoramide is itself controlled; in the United States it is under Schedule I as a Narcotic with an ACSCN of 9645 and a zero annual aggregate manufacturing quota as of 2014. [2] Its salts are the bitartrate (free base conversion ratio 0.723) and dihydrochloride (0.843)
Moramide intermediate is listed separately as a Schedule II Narcotic controlled substance (ACSCN 9802), also with a zero quota.[3]
References
- ↑ C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1375. ISBN 978-0-412-46630-4. Retrieved 29 November 2011.
- ↑ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
- ↑ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
